Edit

ConforMIS

http://www.conformis.com/

Last activity: 08.05.2024

Categories: MedTechPlatformPrintingProductTechnologyDeliveryDesignITMarket

Conformis Inc is a US-based medical technology company. It uses iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of knee replacement market. Its total revenue generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.

Mentions

Location: United States, Massachusetts, Billerica

Total raised: $257M

Investors 2

Date	Name	Website
-	Western Te...	westerntec...
-	YFY Biotec...	tgbfund.co...

Funding Rounds 2

Date	Series	Amount	Investors
02.08.2013	Series E	$168M	-
30.01.2012	Series E	$89M	-

Mentions in press and media 26

Date	Title	Description
08.05.2024	D.C. startup clinches millions for 3D-printed knee implant, but still needs more	-
23.06.2023	Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash	Combination creates a leading personalized 3D-printed orthopedic medical device company /EIN News/ -- DURHAM, N.C. and BILLERICA, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) announced today tha...
22.06.2023	Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash	-
22.03.2022	Conformis announces a credit card partnership	Conformis (Nasdaq:CFMS) officials are betting that a special credit card could get more people to opt for upgraded orthopedic surgeries. The Billerica, Massachusetts–based ortho surgery tech company at AAOS 2022 today announced a partnershi...
18.02.2022	Conformis, Inc. to Participate in Upcoming Investor Conferences	BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, a...
21.01.2022	Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022	BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial results for the fourth quarter and fiscal yea...
06.01.2022	Conformis, Inc. Provides Business Update and Initial Expectations for 2022	Company Launches Innovative Image-to-Implant® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that fea...
06.01.2022	Conformis : Provides Business Update and Initial Expectations for 2022 - Form 8-K	Conformis, Inc. Provides Business Update and Initial Expectations for 2022 Company Launches Innovative Image-to-Implant® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., January 6, 2022 (GLOBE NEWSWIRE) -- ...
03.11.2021	Conformis misses with Q3 results	Conformis (NSDQ:CFMS) posted third-quarter results today that missed the consensus forecast on Wall Street. The Billerica, Massachusetts-based orthopedic medical device company reported a net loss of $13.0 million, or -$0.07 per share, on s...
19.08.2021	Conformis : Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System	BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity Imprint, available in both cruciate retaining (C...
25.02.2021	Conformis, Inc. to Participate in Upcoming Investor Conferences	BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, a...
12.02.2021	Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock	BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an offering price of $1.05 per share. The gross pro...
22.05.2015	ConforMIS files for $173m IPO	ConforMIS today unveiled plans for an initial public offering worth up to $172.5 million, saying it plans to file for FDA approval of its customized hip implant this year. Bedford, Mass.-based ConforMIS said it plans to trade on the NASDAQ ...
05.08.2013	ConforMIS Inc. Expands Series E Funding To $167M	Burlington, Mass.-based custom orthopedic implant maker ConforMIS Inc. expanded its Series E round of funding to $167.7 million on Monday. Sovereign Wealth Funds, government investment and private equity funds in the U.S., Europe, Asia and ...
05.08.2013	ConforMIS Closes Adds $78.7M to Series E	BEDFORD, MA, Privately held medical device company pioneering patient-specific orthopedic implants, announced today it has expanded its Series E financing to $167.7 million. >> Click here for more funding data on ConforMIS >>...
02.08.2013	ConforMIS Raises $167.7M Series E Financing	ConforMIS, Inc., a Bedford, MA-based medical device company developing patient-specific orthopedic implants, has expanded its Series E financing to $167.7m. Backers included Sovereign Wealth Funds, Government Investment Funds and Private Eq...
31.07.2013	ConforMIS raises $168M Series E round	ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings. The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detai...
02.08.2012	Orthopedics device startup wants to win share by providing customized knee implants	“Instead of asking orthopedic surgeons to pick six to 10 standard sizes to fit all different patients they see, every implant that we make is designed to fit you,” said Jong Lee, senior vice president of marketing and business strategy at C...
08.06.2012	ConforMIS seeks $68 million in new funding round	Orthopedics devices maker ConforMIS launched a $68 million funding round that will close at the end of this month. ConforMIS is offering equity, securities and options with no minimum investor, according to regulatory filings. The privately...
30.01.2012	ConforMIS Grabs Mind Blowing $89M	BURLINGTON, MA, Medical device company ConforMIS, Inc. announced that it has raised $89 million in a Series E round of funding. >> Click here for more funding data on ConforMIS >> To export ConforMIS funding data to PDF and ...
30.01.2012	Conformis nets $89 million in Series E round	ConforMIS Inc. said it’s closed another massive funding round to support its line of personalized knee implants. The Burlington, Mass.-based orthopedic device maker said it raised $89 million in a Series E round from several investors, incl...
30.01.2012	ConforMIS Raises $89M in Series E Financing	ConforMIS, Inc., a Burlington, Mass.-based medical-device company, has raised $89m in a Series E funding round. Additional funds beyond this amount will be provided upon meeting certain milestones. Backers include AGC Equity Partners and Ax...
12.07.2011	ConforMIS lands $1.4 million MassDevelopment loan \| Funding Roundup	ConforMIS Inc. is on a roll the announcement that it secured a $1.4 million loan from MassDevelopment’s Emerging Technology Fund. The loan will go toward growing the Burlington, Mass.-based company’s supply chain and manufacturing capacity ...
21.09.2007	Life sciences briefing: Friday, Sept. 21, 2007	Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma (UPDATED on 10/1/07: See below.) [NOTE: Posting has been slow rec...
06.08.2007	Life sciences briefing: Monday, Aug. 6, 2007	(UPDATED at 5:05 p.m. PDT; see below.) (As part of my ongoing effort to strike the right balance between keeping up with venture-business news and writing more analysis, I’m inaugurating a daily briefing that will collect deal-related news ...
-	Orthopedics device startup wants to win share by providing customized knee implants	Sometimes size does matter, especially when it comes to total knee replacements. Until now, patients in the U.S. have had to be content with a small selection of standard sized knee implants. Now, a late-stage orthopedics startup wants to c...

ConforMIS

Investors 2

Funding Rounds 2

Mentions in press and media 26

Reviews 0